Abstract |
Neuroblastoma is the most common childhood solid tumor, yet the prognosis for high-risk disease remains poor. We demonstrate here that arginase 2 (ARG2) drives neuroblastoma cell proliferation via regulation of arginine metabolism. Targeting arginine metabolism, either by blocking cationic amino acid transporter 1 (CAT-1)-dependent arginine uptake in vitro or therapeutic depletion of arginine by pegylated recombinant arginase BCT-100, significantly delayed tumor development and prolonged murine survival. Tumor cells polarized infiltrating monocytes to an M1-macrophage phenotype, which released IL1β and TNFα in a RAC-alpha serine/threonine-protein kinase (AKT)-dependent manner. IL1β and TNFα established a feedback loop to upregulate ARG2 expression via p38 and extracellular regulated kinases 1/2 (ERK1/2) signaling in neuroblastoma and neural crest-derived cells. Proteomic analysis revealed that enrichment of IL1β and TNFα in stage IV human tumor microenvironments was associated with a worse prognosis. These data thus describe an immune-metabolic regulatory loop between tumor cells and infiltrating myeloid cells regulating ARG2, which can be clinically exploited. SIGNIFICANCE: These findings illustrate that cross-talk between myeloid cells and tumor cells creates a metabolic regulatory loop that promotes neuroblastoma progression.
|
Authors | Livingstone Fultang, Laura D Gamble, Luciana Gneo, Andrea M Berry, Sharon A Egan, Fenna De Bie, Orli Yogev, Georgina L Eden, Sarah Booth, Samantha Brownhill, Ashley Vardon, Carmel M McConville, Paul N Cheng, Murray D Norris, Heather C Etchevers, Jayne Murray, David S Ziegler, Louis Chesler, Ronny Schmidt, Susan A Burchill, Michelle Haber, Carmela De Santo, Francis Mussai |
Journal | Cancer research
(Cancer Res)
Vol. 79
Issue 3
Pg. 611-624
(02 01 2019)
ISSN: 1538-7445 [Electronic] United States |
PMID | 30545920
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | ©2018 American Association for Cancer Research. |
Chemical References |
- Interleukin-1beta
- TNF protein, human
- Tumor Necrosis Factor-alpha
- Arginine
- ARG2 protein, human
- Arginase
|
Topics |
- Animals
- Arginase
(metabolism)
- Arginine
(metabolism)
- Cell Line, Tumor
- Humans
- Interleukin-1beta
(immunology, metabolism)
- MAP Kinase Signaling System
- Macrophages
(immunology, metabolism, pathology)
- Mice
- Mice, Transgenic
- Myeloid Cells
(immunology, metabolism, pathology)
- Neuroblastoma
(immunology, metabolism, pathology)
- Sarcoma, Ewing
(immunology, metabolism, pathology)
- Tumor Microenvironment
- Tumor Necrosis Factor-alpha
(immunology, metabolism)
|